Search research articles
Contact Us
Filters
Showing results (11-20 of 133) with videos related to
Page
of 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003
Jonathan D Cheng, Louis M Weiner
Progress in Molecular Biology and Translational Science
|
August 7, 2019
Tumor mechanisms of resistance to immune attack
David J Zahavi, Louis M Weiner
Nature Biotechnology
|
September 10, 2005
Monoclonal antibody therapy of cancer
Gregory P Adams, Louis M Weiner
International Journal of Molecular Sciences
|
January 10, 2019
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
David J Zahavi, Louis M Weiner
Surgical Oncology Clinics of North America
|
November 21, 2007
Monoclonal antibodies in therapy of solid tumors
David M Heimann, Louis M Weiner
Cancer Metastasis Reviews
|
July 1, 2020
The role of fibroblast activation protein in health and malignancy
Allison A Fitzgerald, Louis M Weiner
Methods in Cell Biology
|
October 17, 2025
Imaging mass cytometry-derived single cell extraction, transformation and phenotyping to analyze immune tumor microenvironments
Zoe X Malchiodi, Louis M Weiner
Annals of Internal Medicine
|
September 22, 2010
Supportive treatments for oncology patients: not just icing on the cake
John F Deeken, Louis M Weiner
Cancers
|
February 10, 2024
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Alexander A Lekan, Louis M Weiner
The New England Journal of Medicine
|
March 23, 2012
Tumor-cell death, autophagy, and immunity
Louis M Weiner, Michael T Lotze
Page
of 14
Search research articles
Search
Showing results (11-20 of 133) with videos related to
Sort By:
Page
of 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 10, 2003
Tumors and their microenvironments: tilling the soil. Commentary re: A. M. Scott et al., A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Clin. Cancer Res., 9: 1639-1647, 2003
Jonathan D Cheng, Louis M Weiner
Progress in Molecular Biology and Translational Science
|
August 7, 2019
Tumor mechanisms of resistance to immune attack
David J Zahavi, Louis M Weiner
Nature Biotechnology
|
September 10, 2005
Monoclonal antibody therapy of cancer
Gregory P Adams, Louis M Weiner
International Journal of Molecular Sciences
|
January 10, 2019
Targeting Multiple Receptors to Increase Checkpoint Blockade Efficacy
David J Zahavi, Louis M Weiner
Surgical Oncology Clinics of North America
|
November 21, 2007
Monoclonal antibodies in therapy of solid tumors
David M Heimann, Louis M Weiner
Cancer Metastasis Reviews
|
July 1, 2020
The role of fibroblast activation protein in health and malignancy
Allison A Fitzgerald, Louis M Weiner
Methods in Cell Biology
|
October 17, 2025
Imaging mass cytometry-derived single cell extraction, transformation and phenotyping to analyze immune tumor microenvironments
Zoe X Malchiodi, Louis M Weiner
Annals of Internal Medicine
|
September 22, 2010
Supportive treatments for oncology patients: not just icing on the cake
John F Deeken, Louis M Weiner
Cancers
|
February 10, 2024
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Alexander A Lekan, Louis M Weiner
The New England Journal of Medicine
|
March 23, 2012
Tumor-cell death, autophagy, and immunity
Louis M Weiner, Michael T Lotze
Page
of 14